HEADER    LYASE                                   06-MAY-02   1LOL
OBSLTE     30-SEP-93 1LOL      1SAM
TITLE     CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE
TITLE    2 COMPLEX WITH XMP
SPLIT      1VOQ 1VOR 1VOS 1VOU 1VOV 1VOW 1VOX 1VOY 1VP0 1VOZ 1VOY 1VP0 1VOZ 1VOZ
SPLIT      1VOQ 1VOR 1VOS 1VOU 1VOV 1VOW 1VOX 1VOY 1VP0 1VOZ
CAVEAT     1LOL    THE CRYSTAL TRANSFORMATION IS IN ERROR BUT IS
CAVEAT   2 1LOL    UNCORRECTABLE AT THIS TIME
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE;
COMPND   3 CHAIN: A, B;
COMPND   4 SYNONYM: OMP DECARBOXYLASE, OMPDCASE, OMPDECASE;
COMPND   5 EC: 4.1.1.23;
COMPND   6 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: METHANOTHERMOBACTER
SOURCE   3 THERMAUTOTROPHICUS STR. DELTA H;
SOURCE   4 ORGANISM_TAXID: 187420;
SOURCE   5 STRAIN: DELTA H;
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE   8 EXPRESSION_SYSTEM_PLASMID: PET15B
KEYWDS    TIM BARREL, LYASE
EXPDTA    NEUTRON DIFFRACTION; X-RAY DIFFRACTION
NUMMDL    2
MDLTYP    CA ATOMS ONLY, CHAIN A, B, C, D, E, F, G, H, I, J, K ; P ATOMS ONLY,
MDLTYP   2 CHAIN X, Y, Z
AUTHOR    N.WU,E.F.PAI
REVDAT   4 1 24-FEB-09 1LOL    1       VERSN  COMPND EXPDTA CAVEAT
REVDAT   4 2                   1       SOURCE JRNL
REVDAT   3   01-APR-03 1LOL    1       JRNL
REVDAT   2   14-AUG-02 1LOL    1       DBREF
REVDAT   1   07-AUG-02 1LOL    0
SPRSDE     27-FEB-95 1GDJ      1LH4 2LH4
JRNL        AUTH   N.WU,E.F.PAI
JRNL        TITL   CRYSTAL STRUCTURES OF INHIBITOR COMPLEXES REVEAL
JRNL        TITL 2 AN ALTERNATE BINDING MODE IN
JRNL        TITL 3 OROTIDINE-5'-MONOPHOSPHATE DECARBOXYLASE.
JRNL        EDIT   J.REN,C.NICHOLS,L.BIRD,P.CHAMBERLAIN,K.WEAVER,
JRNL        EDIT 2 S.SHORT,D.I.STUART,D.K.STAMMERS
JRNL        REF    J.BIOL.CHEM.                  V. 277 28080 2002
JRNL        PUBL   AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE
JRNL        PUBL 2 WASHINGTON, D.C.
JRNL        REFN                   ISSN 0021-9258
JRNL        PMID   12011084
JRNL        DOI    10.1074/JBC.M202362200
REMARK   1
REMARK   2
REMARK   2 RESOLUTION.    1.90 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : CNS 0.9
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,
REMARK   3               : READ,RICE,SIMONSON,WARREN
REMARK   3
REMARK   3  REFINEMENT TARGET : ENGH & HUBER
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 27.07
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 679650.230
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.0000
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 97.2
REMARK   3   NUMBER OF REFLECTIONS             : 32092
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK   3   R VALUE            (WORKING SET) : 0.193
REMARK   3   FREE R VALUE                     : 0.229
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 4.900
REMARK   3   FREE R VALUE TEST SET COUNT      : 1583
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.006
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED           : 6
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 1.90
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.02
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 96.40
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 4989
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2340
REMARK   3   BIN FREE R VALUE                    : 0.2620
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 5.30
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 279
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.016
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 3192
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 60
REMARK   3   SOLVENT ATOMS            : 180
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : 11.20
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 24.20
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : 7.19000
REMARK   3    B22 (A**2) : -3.85000
REMARK   3    B33 (A**2) : -3.34000
REMARK   3    B12 (A**2) : 0.00000
REMARK   3    B13 (A**2) : 3.48000
REMARK   3    B23 (A**2) : 0.00000
REMARK   3
REMARK   3  ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL
REMARK   3   ESD FROM SIGMAA              (A) : NULL
REMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL
REMARK   3
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.25
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.20
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.
REMARK   3   BOND LENGTHS                 (A) : 0.009
REMARK   3   BOND ANGLES            (DEGREES) : 1.30
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 22.00
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.97
REMARK   3
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA
REMARK   3   MAIN-CHAIN BOND              (A**2) : 1.450 ; 1.500
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 2.170 ; 2.000
REMARK   3   SIDE-CHAIN BOND              (A**2) : 2.480 ; 2.000
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 3.700 ; 2.500
REMARK   3
REMARK   3  BULK SOLVENT MODELING.
REMARK   3   METHOD USED : FLAT MODEL
REMARK   3   KSOL        : 0.39
REMARK   3   BSOL        : 54.02
REMARK   3
REMARK   3  NCS MODEL : NULL
REMARK   3
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL
REMARK   3
REMARK   3  PARAMETER FILE  1  : PROTEIN_REP.PARAM
REMARK   3  PARAMETER FILE  2  : WATER_REP.PARAM
REMARK   3  PARAMETER FILE  3  : XMP.PARAM
REMARK   3  PARAMETER FILE  4  : DIO.PARAM
REMARK   3  PARAMETER FILE  5  : NULL
REMARK   3  TOPOLOGY FILE  1   : PROTEIN.TOP
REMARK   3  TOPOLOGY FILE  2   : WATER.TOP
REMARK   3  TOPOLOGY FILE  3   : XMP.TOP
REMARK   3  TOPOLOGY FILE  4   : DIO.TOP
REMARK   3  TOPOLOGY FILE  5   : NULL
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: NULL
REMARK   4
REMARK   4 1LOL COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAY-02.
REMARK 100 THE RCSB ID CODE IS RCSB016137.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 12-SEP-01
REMARK 200  TEMPERATURE           (KELVIN) : 100
REMARK 200  PH                             : NULL
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : Y
REMARK 200  RADIATION SOURCE               : APS
REMARK 200  BEAMLINE                       : 14-BM-C
REMARK 200  X-RAY GENERATOR MODEL          : NULL
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.0
REMARK 200  MONOCHROMATOR                  : NULL
REMARK 200  OPTICS                         : NULL
REMARK 200
REMARK 200  DETECTOR TYPE                  : CCD
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 4
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 32685
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.900
REMARK 200  RESOLUTION RANGE LOW       (A) : 100.000
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.0
REMARK 200  DATA REDUNDANCY                : NULL
REMARK 200  R MERGE                    (I) : NULL
REMARK 200  R SYM                      (I) : NULL
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.97
REMARK 200  COMPLETENESS FOR SHELL     (%) : 99.9
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL
REMARK 200  R MERGE FOR SHELL          (I) : NULL
REMARK 200  R SYM FOR SHELL            (I) : NULL
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: EPMR
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 41.59
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: TRISODIUM CITRATE, (+/-)1,3-
REMARK 280  BUTANEDIOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -X,Y+1/2,-Z
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000       27.74100
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE BIOLOGICALLY FUNCTIONAL UNIT IS A DIMER COMPOSED OF
REMARK 300 THE TWO MONOMERS IN THE ASYMMETRIC UNIT.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5230 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 16550 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     LEU A     1
REMARK 465     ARG A     2
REMARK 465     SER A     3
REMARK 465     ARG A     4
REMARK 465     ARG A     5
REMARK 465     VAL A     6
REMARK 465     ASP A     7
REMARK 465     VAL A     8
REMARK 465     MET A     9
REMARK 465     ASP A    10
REMARK 465     VAL A   182
REMARK 465     GLY A   183
REMARK 465     ALA A   184
REMARK 465     GLN A   185
REMARK 465     GLY A   186
REMARK 465     GLY A   187
REMARK 465     ASP A   188
REMARK 465     PRO A   189
REMARK 465     LYS A   223
REMARK 465     ASP A   224
REMARK 465     LEU A   225
REMARK 465     LEU A   226
REMARK 465     ILE A   227
REMARK 465     PRO A   228
REMARK 465     GLU A   229
REMARK 465     LEU B  1001
REMARK 465     ARG B  1002
REMARK 465     SER B  1003
REMARK 465     ARG B  1004
REMARK 465     ARG B  1005
REMARK 465     VAL B  1006
REMARK 465     ASP B  1007
REMARK 465     VAL B  1008
REMARK 465     MET B  1009
REMARK 465     ASP B  1010
REMARK 465     VAL B  1182
REMARK 465     GLY B  1183
REMARK 465     ALA B  1184
REMARK 465     GLN B  1185
REMARK 465     GLY B  1186
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    ASN A  13       14.88     59.51
REMARK 500    LYS A  72       55.66     38.37
REMARK 500    ALA A  74       51.07   -147.78
REMARK 500    ASP A  75     -167.80   -120.04
REMARK 500    ARG A 118     -164.83   -120.23
REMARK 500    PRO A 129       69.04    -68.11
REMARK 500    PHE A 134      -35.74   -134.52
REMARK 500    ALA B1074       49.31   -143.79
REMARK 500    ARG B1118     -166.79   -118.50
REMARK 500    PHE B1134      -30.96   -136.29
REMARK 500    PRO B1157      -77.75    -53.59
REMARK 500    SER B1158      164.32    157.29
REMARK 500    THR B1159     -151.26     47.23
REMARK 500    ARG B1160       85.34     21.26
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525  M RES CSSEQI
REMARK 525    HOH B3180        DISTANCE =  5.07 ANGSTROMS
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BU2 A 5001
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BU2 B 5002
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XMP A 2001
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XMP B 2002
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1LOQ   RELATED DB: PDB
REMARK 900 OROTIDINE MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH UMP
REMARK 900 RELATED ID: 1LOR   RELATED DB: PDB
REMARK 900 OROTIDINE MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH BMP
REMARK 900 RELATED ID: 1LOS   RELATED DB: PDB
REMARK 900 OROTIDINE MONOPHOSPHATE DECARBOXYLASE MUTANT DELTA R203A
REMARK 900 COMPLEXED WITH 6-AZAUMP
REMARK 900 RELATED ID: 1LP6   RELATED DB: PDB
REMARK 900 OROTIDINE MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH CMP
REMARK 999
REMARK 999  SEQUENCE
REMARK 999 AUTHOR STATES THAT ALTHOUGH RESIDUES 1 AND 1001 ARE MET
REMARK 999 AND RESIDUES 101 AND 1101 ARE ARG ACCORDING TO THE
REMARK 999 SWISSPROT ENTRY, RESIDUES 1 AND 1001 WERE LEU AND RESIDUES
REMARK 999 101 AND 1101 WERE PRO IN THE ORIGINAL CONSTRUCT CLONED
REMARK 999 OF MT GENOMIC DNA.
DBREF  1LOL A    1   229  UNP    O26232   PYRF_METTH       1    228
DBREF  1LOL B 1001  1229  UNP    O26232   PYRF_METTH       1    228
DBREF1 1LOL C   61   322  GB                   AE017221
DBREF2 1LOL C     46197919                      1534489     1537377
SEQADV 1LOL GLU A  229  UNP  O26232              INSERTION
SEQADV 1LOL GLU B 1229  UNP  O26232              INSERTION
SEQRES   1 A  229  LEU ARG SER ARG ARG VAL ASP VAL MET ASP VAL MET ASN
SEQRES   2 A  229  ARG LEU ILE LEU ALA MET ASP LEU MET ASN ARG ASP ASP
SEQRES   3 A  229  ALA LEU ARG VAL THR GLY GLU VAL ARG GLU TYR ILE ASP
SEQRES   4 A  229  THR VAL LYS ILE GLY TYR PRO LEU VAL LEU SER GLU GLY
SEQRES   5 A  229  MET ASP ILE ILE ALA GLU PHE ARG LYS ARG PHE GLY CYS
SEQRES   6 A  229  ARG ILE ILE ALA ASP PHE LYS VAL ALA ASP ILE PRO GLU
SEQRES   7 A  229  THR ASN GLU LYS ILE CYS ARG ALA THR PHE LYS ALA GLY
SEQRES   8 A  229  ALA ASP ALA ILE ILE VAL HIS GLY PHE PRO GLY ALA ASP
SEQRES   9 A  229  SER VAL ARG ALA CYS LEU ASN VAL ALA GLU GLU MET GLY
SEQRES  10 A  229  ARG GLU VAL PHE LEU LEU THR GLU MET SER HIS PRO GLY
SEQRES  11 A  229  ALA GLU MET PHE ILE GLN GLY ALA ALA ASP GLU ILE ALA
SEQRES  12 A  229  ARG MET GLY VAL ASP LEU GLY VAL LYS ASN TYR VAL GLY
SEQRES  13 A  229  PRO SER THR ARG PRO GLU ARG LEU SER ARG LEU ARG GLU
SEQRES  14 A  229  ILE ILE GLY GLN ASP SER PHE LEU ILE SER PRO GLY VAL
SEQRES  15 A  229  GLY ALA GLN GLY GLY ASP PRO GLY GLU THR LEU ARG PHE
SEQRES  16 A  229  ALA ASP ALA ILE ILE VAL GLY ARG SER ILE TYR LEU ALA
SEQRES  17 A  229  ASP ASN PRO ALA ALA ALA ALA ALA GLY ILE ILE GLU SER
SEQRES  18 A  229  ILE LYS ASP LEU LEU ILE PRO GLU
SEQRES   1 B  229  LEU ARG SER ARG ARG VAL ASP VAL MET ASP VAL MET ASN
SEQRES   2 B  229  ARG LEU ILE LEU ALA MET ASP LEU MET ASN ARG ASP ASP
SEQRES   3 B  229  ALA LEU ARG VAL THR GLY GLU VAL ARG GLU TYR ILE ASP
SEQRES   4 B  229  THR VAL LYS ILE GLY TYR PRO LEU VAL LEU SER GLU GLY
SEQRES   5 B  229  MET ASP ILE ILE ALA GLU PHE ARG LYS ARG PHE GLY CYS
SEQRES   6 B  229  ARG ILE ILE ALA ASP PHE LYS VAL ALA ASP ILE PRO GLU
SEQRES   7 B  229  THR ASN GLU LYS ILE CYS ARG ALA THR PHE LYS ALA GLY
SEQRES   8 B  229  ALA ASP ALA ILE ILE VAL HIS GLY PHE PRO GLY ALA ASP
SEQRES   9 B  229  SER VAL ARG ALA CYS LEU ASN VAL ALA GLU GLU MET GLY
SEQRES  10 B  229  ARG GLU VAL PHE LEU LEU THR GLU MET SER HIS PRO GLY
SEQRES  11 B  229  ALA GLU MET PHE ILE GLN GLY ALA ALA ASP GLU ILE ALA
SEQRES  12 B  229  ARG MET GLY VAL ASP LEU GLY VAL LYS ASN TYR VAL GLY
SEQRES  13 B  229  PRO SER THR ARG PRO GLU ARG LEU SER ARG LEU ARG GLU
SEQRES  14 B  229  ILE ILE GLY GLN ASP SER PHE LEU ILE SER PRO GLY VAL
SEQRES  15 B  229  GLY ALA GLN GLY GLY ASP PRO GLY GLU THR LEU ARG PHE
SEQRES  16 B  229  ALA ASP ALA ILE ILE VAL GLY ARG SER ILE TYR LEU ALA
SEQRES  17 B  229  ASP ASN PRO ALA ALA ALA ALA ALA GLY ILE ILE GLU SER
SEQRES  18 B  229  ILE LYS ASP LEU LEU ILE PRO GLU
MODRES 1LOL ASP A   10  ASP  GLYCOSYLATION SITE
HET    BU2  A5001       6
HET    BU2  B5002       6
HET    XMP  A2001      24
HET    XMP  B2002      24
HETNAM     BU2 1,3-BUTANEDIOL
HETNAM     XMP XANTHOSINE-5'-MONOPHOSPHATE
HETSYN     BU2 BOOM BOOM BOMB; WYRDSTUFF
HETSYN     XMP 5-MONOPHOSPHATE-9-BETA-D-RIBOFURANOSYL XANTHINE
FORMUL   3  BU2    2(C4 H10 O2)
FORMUL   5  XMP    2(C10 H14 N4 O9 P 1+)
FORMUL   7  HOH   *180(H2 O)
HELIX    1   1 VAL A   11  ASN A   13  5                                   3
HELIX    2   2 ASN A   23  ARG A   35  1                                  13
SHEET    1   A 2 LEU A  15  MET A  19  0
SHEET    2   A 2 THR A  40  GLY A  44  1  O  LYS A  42   N  LEU A  17
SSBOND   1 CYS A  123    CYS A  155                          1555   1555  2.04
LINK         O   TYR A 146                 K     K A 501     1555   1555  2.75
LINK         OG1 THR A 143                 K     K A 504     1555   1555
CISPEP     ASP B 1188    PRO B 1189          0         0.35
SITE     1 AC1  6 ASP A  70  LYS A  72  LEU A 123  VAL A 155
SITE     2 AC1  6 XMP A2001  HOH A3015
SITE     1 AC3  8 ALA A  18  ASP A  20  LYS A  42  ASP A  70
SITE     2 AC3  8 MET A 126  SER A 127  SER A 158  PRO A 180
